PMID: 3321356Nov 1, 1987Paper

Health and economic impacts of antimicrobial resistance

Reviews of Infectious Diseases
S D HolmbergP A Blake

Abstract

For comparison of the impacts of infections due to antimicrobial-resistant bacteria with those of infections due to antimicrobial-susceptible strains of the same bacteria, data were evaluated from 175 published and unpublished reports of investigations of nosocomial and community-acquired infections with selected bacteria. The evaluation of outcomes of hospital-acquired infections with resistant organisms was often confounded by risk factors also associated with poor outcomes. Nevertheless, for both nosocomial and community-acquired infections, the mortality, the likelihood of hospitalization, and the length of hospital stay were usually at least twice as great for patients infected with drug-resistant strains as for those infected with drug-susceptible strains of the same bacteria. Poor outcomes could be attributed both to the expected effects of ineffective antimicrobial therapy and to the unexpected occurrence of drug-resistant infections complicated by prior antimicrobial therapy for other medical problems. Although the adverse economic and health effects of drug-resistant bacterial infections can only be roughly quantified, it is concluded that antimicrobial resistance is an important health problem and an economic burden ...Continue Reading

Citations

Aug 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F NavarroG Prats
Jan 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C M Vandenbroucke-Grauls
Sep 1, 1999·Immunologic Research·B Mehrad, T J Standiford
Jun 5, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E RaineriA Candiani
Feb 1, 1993·Diagnostic Microbiology and Infectious Disease·B MirelisG Prats
Jan 1, 1993·International Journal of Antimicrobial Agents·I A HolderA N Neely
May 21, 2005·The Journal of Infection·Marc H ScheetzMichael J Postelnick
Dec 29, 2004·Médecine et maladies infectieuses·Linda Tollefson, Beth E Karp
Dec 12, 2002·Journal of Health Economics·Niklas Rudholm
Mar 18, 2000·International Journal of Antimicrobial Agents·T J Shaar, R Al-Hajjar
Mar 3, 2004·Clinical Cornerstone·Daniel F Sahm
Apr 28, 1994·The New England Journal of Medicine·B E Murray
Jan 8, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David H HowardDeAnn Jones
May 27, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara E Cosgrove, Yehuda Carmeli
Sep 11, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Theoklis E Zaoutis
Mar 7, 2000·The Journal of Antimicrobial Chemotherapy·A R BremónR L Rodríguez
Dec 11, 1997·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A DigranesJ Sander
Mar 23, 2011·Antimicrobial Agents and Chemotherapy·Catharine C Bulik, David P Nicolau
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·D ReadyM Wilson
May 27, 2005·Antimicrobial Agents and Chemotherapy·John WeigeltUNKNOWN Linezolid CSSTI Study Group
Aug 14, 2012·Applied and Environmental Microbiology·Thomas E WittumMatthew M Erdman
Jan 15, 2011·Clinical Microbiology Reviews·Emily R M Sydnor, Trish M Perl
Sep 1, 1996·Archives of Disease in Childhood·Z A Bhutta
Dec 21, 2000·Critical Care : the Official Journal of the Critical Care Forum·M H Kollef
Apr 1, 1996·Emerging Infectious Diseases·C B KronenbergerW M Marine
Jan 21, 2003·Emerging Infectious Diseases·W Michael Scheld
Oct 5, 2007·Expert Review of Anti-infective Therapy·Philip D Lister
Feb 24, 2011·Expert Review of Anti-infective Therapy·Paola Stefanelli
Nov 26, 2005·Expert Review of Anti-infective Therapy·Stephen H Zinner
Jul 2, 2005·Expert Opinion on Emerging Drugs·G W Kaatz, M J Rybak
May 27, 2014·Clinics in Laboratory Medicine·Gerald A Denys, Ryan F Relich
Apr 30, 2009·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·M V Gil-NavarroJ Bautista Paloma
Jun 24, 2010·Preventive Veterinary Medicine·Ivar Vågsholm, Sören Höjgård

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Related Papers

Indian Journal of Urology : IJU : Journal of the Urological Society of India
Umesh S KamatManoj S Kulkarni
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
J C Pechère
© 2021 Meta ULC. All rights reserved